<DOC>
	<DOCNO>NCT00207025</DOCNO>
	<brief_summary>The purpose clinical research study learn safety tolerability daily BMS-275183 patient advance cancer .</brief_summary>
	<brief_title>A Phase I Study BMS-275183 Given Daily Schedule Patients With Advanced Malignancies</brief_title>
	<detailed_description />
	<criteria>Nonhematologic malignancy progress standard therapy know Four week last chemotherapy two week last noncytotoxic therapy Eastern Cooperative Oncology Group ( ECOG ) Performance Status 01 No 3 prior chemotherapy regimen advanced/metastatic set Absolute neutrophil count &gt; =1,500/mm3 platelet &gt; =100,000/mm3 Bilirubin &lt; =1.5 x Upper Limit Normal ( ULN ) , Aspartate aminotransferase &lt; =2.5 x ULN Serum creatinine &lt; =1.5 x ULN Men woman &gt; =18 year Women Child Bearing Potential ( WOCBP ) must use adequate method contraception throughout 4 week study WOCBP men use adequate method birth control WOCBP pregnant breastfeeding Prior radiation &gt; =25 % bone marrow contain skeleton Uncontrolled , significant , active cardiovascular pulmonary disease infection psychiatric disorder Neuropathy Active brain metastasis Inability swallow capsule History gastrointestinal disease , surgery malabsorption , require use feed tube Concurrent chemotherapy , hormonal therapy , immunotherapy , radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Patients advance solid tumor</keyword>
</DOC>